Molecule Holdings Stock Probability of Future Pink Sheet Price Finishing Over 0.0025

EVRRF Stock  USD 0  0.00  0.00%   
Molecule Holdings' future price is the expected price of Molecule Holdings instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Molecule Holdings performance during a given time horizon utilizing its historical volatility. Check out Molecule Holdings Backtesting, Molecule Holdings Valuation, Molecule Holdings Correlation, Molecule Holdings Hype Analysis, Molecule Holdings Volatility, Molecule Holdings History as well as Molecule Holdings Performance.
  
Please specify Molecule Holdings' target price for which you would like Molecule Holdings odds to be computed.

Molecule Holdings Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Molecule Holdings for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Molecule Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Molecule Holdings generated a negative expected return over the last 90 days
Molecule Holdings has some characteristics of a very speculative penny stock
Molecule Holdings has a very high chance of going through financial distress in the upcoming years
Molecule Holdings has accumulated 817.09 K in total debt with debt to equity ratio (D/E) of 1.37, which is about average as compared to similar companies. Molecule Holdings has a current ratio of 0.3, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Molecule Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Molecule Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Molecule Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Molecule to invest in growth at high rates of return. When we think about Molecule Holdings' use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 455.26 K. Net Loss for the year was (4.23 M) with loss before overhead, payroll, taxes, and interest of (499.74 K).
Molecule Holdings has accumulated about 73.25 K in cash with (2.87 M) of positive cash flow from operations.
Roughly 17.0% of Molecule Holdings shares are held by company insiders

Molecule Holdings Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Molecule Pink Sheet often depends not only on the future outlook of the current and potential Molecule Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Molecule Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding95.4 M
Short Long Term Debt3.5 M
Shares Float81.8 M

Molecule Holdings Technical Analysis

Molecule Holdings' future price can be derived by breaking down and analyzing its technical indicators over time. Molecule Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Molecule Holdings. In general, you should focus on analyzing Molecule Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Molecule Holdings Predictive Forecast Models

Molecule Holdings' time-series forecasting models is one of many Molecule Holdings' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Molecule Holdings' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Molecule Holdings

Checking the ongoing alerts about Molecule Holdings for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Molecule Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Molecule Holdings generated a negative expected return over the last 90 days
Molecule Holdings has some characteristics of a very speculative penny stock
Molecule Holdings has a very high chance of going through financial distress in the upcoming years
Molecule Holdings has accumulated 817.09 K in total debt with debt to equity ratio (D/E) of 1.37, which is about average as compared to similar companies. Molecule Holdings has a current ratio of 0.3, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Molecule Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Molecule Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Molecule Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Molecule to invest in growth at high rates of return. When we think about Molecule Holdings' use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 455.26 K. Net Loss for the year was (4.23 M) with loss before overhead, payroll, taxes, and interest of (499.74 K).
Molecule Holdings has accumulated about 73.25 K in cash with (2.87 M) of positive cash flow from operations.
Roughly 17.0% of Molecule Holdings shares are held by company insiders

Other Information on Investing in Molecule Pink Sheet

Molecule Holdings financial ratios help investors to determine whether Molecule Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Molecule with respect to the benefits of owning Molecule Holdings security.